| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| GRF.MC - Grifols SA | HOLD | 0 @ 10.1096 | 0 | |
| RHC.AX - | HOLD | 0 @ 21.5782 | 0 | |
| 4528.T - Ono Pharmaceutical Co., Ltd. | SELL | -200 @ JPY 10.7187 | JPY -2,144 | The ETF sold 200 shares of 4528.T on 2025-02-25. The shares were previously bought for an average price of JPY 11.1226. The Ono Pharmaceutical Co., Ltd. shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of JPY 81 (USD $1) The average price that the ETF previously sold 4528.T share for is JPY so the ETF has sold 200 shares on 2025-02-25 at a higher price than the previous selling average. |
| CRL - Creightons Plc | SELL | -13 @ 167.1 | -2,172 | The ETF sold 13 shares of CRL on 2025-02-25. The shares were previously bought for an average price of . The Creightons Plc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold CRL share for is so the ETF has sold 13 shares on 2025-02-25 at a higher price than the previous selling average. |
| BIO - Bio-Rad Laboratories Inc | SELL | -8 @ 277.359 | -2,219 | The ETF sold 8 shares of BIO on 2025-02-25. The shares were previously bought for an average price of . The Bio-Rad Laboratories Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BIO share for is so the ETF has sold 8 shares on 2025-02-25 at a higher price than the previous selling average. |
| BIO - Biotest Aktiengesellschaft | SELL | -8 @ 277.359 | -2,219 | The ETF sold 8 shares of BIO on 2025-02-25. The shares were previously bought for an average price of . The Biotest Aktiengesellschaft shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BIO share for is so the ETF has sold 8 shares on 2025-02-25 at a higher price than the previous selling average. |
| BANB.SW - | SELL | -35 @ 65.1893 | -2,282 | The ETF sold 35 shares of BANB.SW on 2025-02-25. The shares were previously bought for an average price of 77.7896. The shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of 441 The average price that the ETF previously sold BANB.SW share for is so the ETF has sold 35 shares on 2025-02-25 at a higher price than the previous selling average. |
| AFX.DE - Carl Zeiss Meditec AG | SELL | -39 @ 59.1037 | -2,305 | The ETF sold 39 shares of AFX.DE on 2025-02-25. The shares were previously bought for an average price of . The Carl Zeiss Meditec AG shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold AFX.DE share for is so the ETF has sold 39 shares on 2025-02-25 at a higher price than the previous selling average. |
| TFX - Teleflex Incorporated | SELL | -13 @ 177.63 | -2,309 | The ETF sold 13 shares of TFX on 2025-02-25. The shares were previously bought for an average price of . The Teleflex Incorporated shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold TFX share for is so the ETF has sold 13 shares on 2025-02-25 at a higher price than the previous selling average. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -43 @ 56.3741 | -2,424 | The ETF sold 43 shares of REC.MI on 2025-02-25. The shares were previously bought for an average price of . The Recordati Industria Chimica e Farmaceutica SpA shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold REC.MI share for is so the ETF has sold 43 shares on 2025-02-25 at a higher price than the previous selling average. |
| DVA - DaVita HealthCare Partners Inc | SELL | -17 @ 142.98 | -2,431 | The ETF sold 17 shares of DVA on 2025-02-25. The shares were previously bought for an average price of . The DaVita HealthCare Partners Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold DVA share for is so the ETF has sold 17 shares on 2025-02-25 at a higher price than the previous selling average. |
| IPN.PA - Ipsen SA | SELL | -21 @ 119.047 | -2,500 | The ETF sold 21 shares of IPN.PA on 2025-02-25. The shares were previously bought for an average price of . The Ipsen SA shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold IPN.PA share for is so the ETF has sold 21 shares on 2025-02-25 at a higher price than the previous selling average. |
| DIM.PA - Sartorius Stedim Biotech | SELL | -12 @ 210.695 | -2,528 | The ETF sold 12 shares of DIM.PA on 2025-02-25. The shares were previously bought for an average price of . The Sartorius Stedim Biotech shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold DIM.PA share for is so the ETF has sold 12 shares on 2025-02-25 at a higher price than the previous selling average. |
| TECH - Bio-Techne Corp | SELL | -40 @ 64.22 | -2,569 | The ETF sold 40 shares of TECH on 2025-02-25. The shares were previously bought for an average price of . The Bio-Techne Corp shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold TECH share for is so the ETF has sold 40 shares on 2025-02-25 at a higher price than the previous selling average. |
| ZEAL.CO - | SELL | -26 @ 101.189 | -2,631 | The ETF sold 26 shares of ZEAL.CO on 2025-02-25. The shares were previously bought for an average price of 95.743. The shares were sold for 5.7% higher than average price of previous purchases. This sale made a profit of 142 The average price that the ETF previously sold ZEAL.CO share for is so the ETF has sold 26 shares on 2025-02-25 at a higher price than the previous selling average. |
| 2413.T - M3, Inc. | SELL | -200 @ JPY 13.4085 | JPY -2,682 | The ETF sold 200 shares of 2413.T on 2025-02-25. The shares were previously bought for an average price of JPY . The M3, Inc. shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold 2413.T share for is JPY so the ETF has sold 200 shares on 2025-02-25 at a higher price than the previous selling average. |
| DIA.MI - DiaSorin SpA | SELL | -26 @ 105.295 | -2,738 | The ETF sold 26 shares of DIA.MI on 2025-02-25. The shares were previously bought for an average price of . The DiaSorin SpA shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold DIA.MI share for is so the ETF has sold 26 shares on 2025-02-25 at a higher price than the previous selling average. |
| NBIX - Neurocrine Biosciences Inc | SELL | -24 @ 115.9 | -2,782 | The ETF sold 24 shares of NBIX on 2025-02-25. The shares were previously bought for an average price of . The Neurocrine Biosciences Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold NBIX share for is so the ETF has sold 24 shares on 2025-02-25 at a higher price than the previous selling average. |
| FME.DE - Fresenius Medical Care AG | SELL | -60 @ 46.4222 | -2,785 | The ETF sold 60 shares of FME.DE on 2025-02-25. The shares were previously bought for an average price of . The Fresenius Medical Care AG shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold FME.DE share for is so the ETF has sold 60 shares on 2025-02-25 at a higher price than the previous selling average. |
| SOBI.ST - | SELL | -95 @ 29.4609 | -2,799 | The ETF sold 95 shares of SOBI.ST on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold SOBI.ST share for is so the ETF has sold 95 shares on 2025-02-25 at a higher price than the previous selling average. |
| ERF.PA - Eurofins Scientific SE | SELL | -55 @ 51.1357 | -2,812 | The ETF sold 55 shares of ERF.PA on 2025-02-25. The shares were previously bought for an average price of 49.7261. The Eurofins Scientific SE shares were sold for 2.8% higher than average price of previous purchases. This sale made a profit of 78 The average price that the ETF previously sold ERF.PA share for is so the ETF has sold 55 shares on 2025-02-25 at a higher price than the previous selling average. |
| SHL.AX - | SELL | -156 @ 18.0441 | -2,815 | The ETF sold 156 shares of SHL.AX on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold SHL.AX share for is so the ETF has sold 156 shares on 2025-02-25 at a higher price than the previous selling average. |
| RO.SW - | SELL | -8 @ 357.227 | -2,858 | The ETF sold 8 shares of RO.SW on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold RO.SW share for is so the ETF has sold 8 shares on 2025-02-25 at a higher price than the previous selling average. |
| HSIC - Henry Schein Inc | SELL | -38 @ 75.8199 | -2,881 | The ETF sold 38 shares of HSIC on 2025-02-25. The shares were previously bought for an average price of . The Henry Schein Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold HSIC share for is so the ETF has sold 38 shares on 2025-02-25 at a higher price than the previous selling average. |
| EXAS - EXACT Sciences Corporation | SELL | -58 @ 50.1799 | -2,910 | The ETF sold 58 shares of EXAS on 2025-02-25. The shares were previously bought for an average price of 54.7499. The EXACT Sciences Corporation shares were sold for -8.3% lower than average price of previous purchases. This resulted in an overall loss of 265 The average price that the ETF previously sold EXAS share for is so the ETF has sold 58 shares on 2025-02-25 at a higher price than the previous selling average. |
| ORNBV.HE - Orion Oyj | SELL | -51 @ 58.6628 | -2,992 | The ETF sold 51 shares of ORNBV.HE on 2025-02-25. The shares were previously bought for an average price of . The Orion Oyj shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold ORNBV.HE share for is so the ETF has sold 51 shares on 2025-02-25 at a higher price than the previous selling average. |
| FPH.NZ - | SELL | -153 @ 19.7184 | -3,017 | The ETF sold 153 shares of FPH.NZ on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold FPH.NZ share for is so the ETF has sold 153 shares on 2025-02-25 at a higher price than the previous selling average. |
| GETI-B.ST - | SELL | -147 @ 20.6113 | -3,030 | The ETF sold 147 shares of GETI-B.ST on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold GETI-B.ST share for is so the ETF has sold 147 shares on 2025-02-25 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -41 @ 74.3999 | -3,050 | The ETF sold 41 shares of INCY on 2025-02-25. The shares were previously bought for an average price of . The Incyte Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold INCY share for is so the ETF has sold 41 shares on 2025-02-25 at a higher price than the previous selling average. |
| 4507.T - Shionogi & Co., Ltd. | SELL | -200 @ JPY 15.6085 | JPY -3,122 | The ETF sold 200 shares of 4507.T on 2025-02-25. The shares were previously bought for an average price of JPY . The Shionogi & Co., Ltd. shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold 4507.T share for is JPY so the ETF has sold 200 shares on 2025-02-25 at a higher price than the previous selling average. |
| SN.L - Smith & Nephew PLC | SELL | -229 @ 14.0137 | -3,209 | The ETF sold 229 shares of SN.L on 2025-02-25. The shares were previously bought for an average price of . The Smith & Nephew PLC shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold SN.L share for is so the ETF has sold 229 shares on 2025-02-25 at a higher price than the previous selling average. |
| BIM.PA - BioMerieux | SELL | -27 @ 119.782 | -3,234 | The ETF sold 27 shares of BIM.PA on 2025-02-25. The shares were previously bought for an average price of . The BioMerieux shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BIM.PA share for is so the ETF has sold 27 shares on 2025-02-25 at a higher price than the previous selling average. |
| HIK.L - | SELL | -112 @ 29.0525 | -3,254 | The ETF sold 112 shares of HIK.L on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold HIK.L share for is so the ETF has sold 112 shares on 2025-02-25 at a higher price than the previous selling average. |
| BMRN - Biomarin Pharmaceutical Inc | SELL | -46 @ 71.1701 | -3,274 | The ETF sold 46 shares of BMRN on 2025-02-25. The shares were previously bought for an average price of . The Biomarin Pharmaceutical Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BMRN share for is so the ETF has sold 46 shares on 2025-02-25 at a higher price than the previous selling average. |
| GALD.SW - | SELL | -27 @ 124.917 | -3,373 | The ETF sold 27 shares of GALD.SW on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold GALD.SW share for is so the ETF has sold 27 shares on 2025-02-25 at a higher price than the previous selling average. |
| PME.AX - | SELL | -19 @ 179.561 | -3,412 | The ETF sold 19 shares of PME.AX on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold PME.AX share for is so the ETF has sold 19 shares on 2025-02-25 at a higher price than the previous selling average. |
| SOLV - Solventum Corp. | SELL | -42 @ 83.5599 | -3,510 | The ETF sold 42 shares of SOLV on 2025-02-25. The shares were previously bought for an average price of . The Solventum Corp. shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold SOLV share for is so the ETF has sold 42 shares on 2025-02-25 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -19 @ 186.62 | -3,546 | The ETF sold 19 shares of ALGN on 2025-02-25. The shares were previously bought for an average price of . The Align Technology Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold ALGN share for is so the ETF has sold 19 shares on 2025-02-25 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -310 @ 11.48 | -3,559 | The ETF sold 310 shares of VTRS on 2025-02-25. The shares were previously bought for an average price of . The Viatris Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold VTRS share for is so the ETF has sold 310 shares on 2025-02-25 at a higher price than the previous selling average. |
| RPRX - Royalty Pharma Plc | SELL | -107 @ 33.69 | -3,605 | The ETF sold 107 shares of RPRX on 2025-02-25. The shares were previously bought for an average price of . The Royalty Pharma Plc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold RPRX share for is so the ETF has sold 107 shares on 2025-02-25 at a higher price than the previous selling average. |
| ILMN - Illumina Inc | SELL | -40 @ 95.7599 | -3,830 | The ETF sold 40 shares of ILMN on 2025-02-25. The shares were previously bought for an average price of . The Illumina Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold ILMN share for is so the ETF has sold 40 shares on 2025-02-25 at a higher price than the previous selling average. |
| STMN.SW - | SELL | -28 @ 139.5 | -3,906 | The ETF sold 28 shares of STMN.SW on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold STMN.SW share for is so the ETF has sold 28 shares on 2025-02-25 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -34 @ 115.49 | -3,927 | The ETF sold 34 shares of RVTY on 2025-02-25. The shares were previously bought for an average price of . The Revvity Inc. shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold RVTY share for is so the ETF has sold 34 shares on 2025-02-25 at a higher price than the previous selling average. |
| UTHR - United Therapeutics Corporation | SELL | -11 @ 357.5 | -3,933 | The ETF sold 11 shares of UTHR on 2025-02-25. The shares were previously bought for an average price of . The United Therapeutics Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold UTHR share for is so the ETF has sold 11 shares on 2025-02-25 at a higher price than the previous selling average. |
| SHL.DE - Siemens Healthineers AG | SELL | -71 @ 56.9201 | -4,041 | The ETF sold 71 shares of SHL.DE on 2025-02-25. The shares were previously bought for an average price of . The Siemens Healthineers AG shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold SHL.DE share for is so the ETF has sold 71 shares on 2025-02-25 at a higher price than the previous selling average. |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -106 @ 38.3807 | -4,068 | The ETF sold 106 shares of FRE.DE on 2025-02-25. The shares were previously bought for an average price of . The Fresenius SE & Co KGaA shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold FRE.DE share for is so the ETF has sold 106 shares on 2025-02-25 at a higher price than the previous selling average. |
| 7733.T - Olympus Corporation | SELL | -300 @ JPY 13.9384 | JPY -4,182 | The ETF sold 300 shares of 7733.T on 2025-02-25. The shares were previously bought for an average price of JPY . The Olympus Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold 7733.T share for is JPY so the ETF has sold 300 shares on 2025-02-25 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -19 @ 220.15 | -4,183 | The ETF sold 19 shares of WST on 2025-02-25. The shares were previously bought for an average price of . The West Pharmaceutical Services Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold WST share for is so the ETF has sold 19 shares on 2025-02-25 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -51 @ 90.2599 | -4,603 | The ETF sold 51 shares of COO on 2025-02-25. The shares were previously bought for an average price of . The The Cooper Companies, Inc. Common Stock shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold COO share for is so the ETF has sold 51 shares on 2025-02-25 at a higher price than the previous selling average. |
| SDZ.SW - | SELL | -104 @ 45.1234 | -4,693 | The ETF sold 104 shares of SDZ.SW on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold SDZ.SW share for is so the ETF has sold 104 shares on 2025-02-25 at a higher price than the previous selling average. |
| TEVA - Teva Pharma Industries Ltd ADR | SELL | -283 @ 16.61 | -4,701 | The ETF sold 283 shares of TEVA on 2025-02-25. The shares were previously bought for an average price of . The Teva Pharma Industries Ltd ADR shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold TEVA share for is so the ETF has sold 283 shares on 2025-02-25 at a higher price than the previous selling average. |
| MRK.DE - Merck KGaA | SELL | -33 @ 143.98 | -4,751 | The ETF sold 33 shares of MRK.DE on 2025-02-25. The shares were previously bought for an average price of . The Merck KGaA shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold MRK.DE share for is so the ETF has sold 33 shares on 2025-02-25 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -18 @ 266.68 | -4,800 | The ETF sold 18 shares of PODD on 2025-02-25. The shares were previously bought for an average price of . The Insulet Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold PODD share for is so the ETF has sold 18 shares on 2025-02-25 at a higher price than the previous selling average. |
| BAX - Baxter International Inc | SELL | -136 @ 35.94 | -4,888 | The ETF sold 136 shares of BAX on 2025-02-25. The shares were previously bought for an average price of . The Baxter International Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BAX share for is so the ETF has sold 136 shares on 2025-02-25 at a higher price than the previous selling average. |
| DGX - Quest Diagnostics Incorporated | SELL | -28 @ 175.41 | -4,911 | The ETF sold 28 shares of DGX on 2025-02-25. The shares were previously bought for an average price of . The Quest Diagnostics Incorporated shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold DGX share for is so the ETF has sold 28 shares on 2025-02-25 at a higher price than the previous selling average. |
| 4578.T - Otsuka Holdings Co., Ltd. | SELL | -100 @ JPY 49.294 | JPY -4,929 | The ETF sold 100 shares of 4578.T on 2025-02-25. The shares were previously bought for an average price of JPY 56.9994. The Otsuka Holdings Co., Ltd. shares were sold for -13.5% lower than average price of previous purchases. This resulted in an overall loss of JPY 771 (USD $5) The average price that the ETF previously sold 4578.T share for is JPY so the ETF has sold 100 shares on 2025-02-25 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -37 @ 143.46 | -5,308 | The ETF sold 37 shares of BIIB on 2025-02-25. The shares were previously bought for an average price of . The Biogen Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BIIB share for is so the ETF has sold 37 shares on 2025-02-25 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -21 @ 252.87 | -5,310 | The ETF sold 21 shares of LH on 2025-02-25. The shares were previously bought for an average price of . The Laboratory Corporation of America Holdings shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold LH share for is so the ETF has sold 21 shares on 2025-02-25 at a higher price than the previous selling average. |
| PHIA.AS - Koninklijke Philips NV | SELL | -202 @ 26.518 | -5,357 | The ETF sold 202 shares of PHIA.AS on 2025-02-25. The shares were previously bought for an average price of . The Koninklijke Philips NV shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold PHIA.AS share for is so the ETF has sold 202 shares on 2025-02-25 at a higher price than the previous selling average. |
| 4543.T - Terumo Corporation | SELL | -300 @ JPY 17.8891 | JPY -5,367 | The ETF sold 300 shares of 4543.T on 2025-02-25. The shares were previously bought for an average price of JPY . The Terumo Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold 4543.T share for is JPY so the ETF has sold 300 shares on 2025-02-25 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -53 @ 107.35 | -5,690 | The ETF sold 53 shares of ZBH on 2025-02-25. The shares were previously bought for an average price of . The Zimmer Biomet Holdings Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold ZBH share for is so the ETF has sold 53 shares on 2025-02-25 at a higher price than the previous selling average. |
| BAYN.DE - Bayer AG | SELL | -244 @ 23.7675 | -5,799 | The ETF sold 244 shares of BAYN.DE on 2025-02-25. The shares were previously bought for an average price of . The Bayer AG shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BAYN.DE share for is so the ETF has sold 244 shares on 2025-02-25 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -5 @ 1308.89 | -6,544 | The ETF sold 5 shares of MTD on 2025-02-25. The shares were previously bought for an average price of . The Mettler-Toledo International Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold MTD share for is so the ETF has sold 5 shares on 2025-02-25 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -5 @ 1308.89 | -6,544 | The ETF sold 5 shares of MTD on 2025-02-25. The shares were previously bought for an average price of . The AMUNDI EUR GOV 710 shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold MTD share for is so the ETF has sold 5 shares on 2025-02-25 at a higher price than the previous selling average. |
| ALNY - Alnylam Pharmaceuticals Inc | SELL | -31 @ 245.2 | -7,601 | The ETF sold 31 shares of ALNY on 2025-02-25. The shares were previously bought for an average price of . The Alnylam Pharmaceuticals Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold ALNY share for is so the ETF has sold 31 shares on 2025-02-25 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -95 @ 88.32 | -8,390 | The ETF sold 95 shares of DXCM on 2025-02-25. The shares were previously bought for an average price of . The DexCom Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold DXCM share for is so the ETF has sold 95 shares on 2025-02-25 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -36 @ 236.19 | -8,503 | The ETF sold 36 shares of RMD on 2025-02-25. The shares were previously bought for an average price of . The ResMed Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold RMD share for is so the ETF has sold 36 shares on 2025-02-25 at a higher price than the previous selling average. |
| AMP.MI - Amplifon SpA | SELL | -332 @ 25.8461 | -8,581 | The ETF sold 332 shares of AMP.MI on 2025-02-25. The shares were previously bought for an average price of . The Amplifon SpA shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold AMP.MI share for is so the ETF has sold 332 shares on 2025-02-25 at a higher price than the previous selling average. |
| ARGX.BR - Argenx SE | SELL | -15 @ 628.201 | -9,423 | The ETF sold 15 shares of ARGX.BR on 2025-02-25. The shares were previously bought for an average price of . The Argenx SE shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold ARGX.BR share for is so the ETF has sold 15 shares on 2025-02-25 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -115 @ 90.81 | -10,443 | The ETF sold 115 shares of GEHC on 2025-02-25. The shares were previously bought for an average price of 86.93. The GE HealthCare Technologies Inc. shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of 446 The average price that the ETF previously sold GEHC share for is so the ETF has sold 115 shares on 2025-02-25 at a higher price than the previous selling average. |
| LONN.SW - | SELL | -17 @ 647.082 | -11,000 | The ETF sold 17 shares of LONN.SW on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold LONN.SW share for is so the ETF has sold 17 shares on 2025-02-25 at a higher price than the previous selling average. |
| 4502.T - Takeda Pharmaceutical Company Limited | SELL | -400 @ JPY 28.7219 | JPY -11,489 | The ETF sold 400 shares of 4502.T on 2025-02-25. The shares were previously bought for an average price of JPY . The Takeda Pharmaceutical Company Limited shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold 4502.T share for is JPY so the ETF has sold 400 shares on 2025-02-25 at a higher price than the previous selling average. |
| 7741.T - HOYA Corporation | SELL | -100 @ JPY 120.569 | JPY -12,057 | The ETF sold 100 shares of 7741.T on 2025-02-25. The shares were previously bought for an average price of JPY 128.458. The HOYA Corporation shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of JPY 789 (USD $5) The average price that the ETF previously sold 7741.T share for is JPY so the ETF has sold 100 shares on 2025-02-25 at a higher price than the previous selling average. |
| DEMANT.CO - | SELL | -431 @ 36.7037 | -15,819 | The ETF sold 431 shares of DEMANT.CO on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold DEMANT.CO share for is so the ETF has sold 431 shares on 2025-02-25 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -48 @ 333.07 | -15,987 | The ETF sold 48 shares of HCA on 2025-02-25. The shares were previously bought for an average price of . The HCA Holdings Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold HCA share for is so the ETF has sold 48 shares on 2025-02-25 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -70 @ 230.05 | -16,104 | The ETF sold 70 shares of BDX on 2025-02-25. The shares were previously bought for an average price of . The Becton Dickinson and Company shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BDX share for is so the ETF has sold 70 shares on 2025-02-25 at a higher price than the previous selling average. |
| 4151.T - Kyowa Kirin Co., Ltd. | SELL | -1,200 @ JPY 14.0088 | JPY -16,811 | The ETF sold 1200 shares of 4151.T on 2025-02-25. The shares were previously bought for an average price of JPY . The Kyowa Kirin Co., Ltd. shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold 4151.T share for is JPY so the ETF has sold 1200 shares on 2025-02-25 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -26 @ 723.47 | -18,810 | The ETF sold 26 shares of REGN on 2025-02-25. The shares were previously bought for an average price of . The Regeneron Pharmaceuticals Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold REGN share for is so the ETF has sold 26 shares on 2025-02-25 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -1,012 @ 18.7715 | -18,997 | The ETF sold 1012 shares of GSK.L on 2025-02-25. The shares were previously bought for an average price of . The GlaxoSmithKline PLC shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold GSK.L share for is so the ETF has sold 1012 shares on 2025-02-25 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -301 @ 63.66 | -19,162 | The ETF sold 301 shares of CVS on 2025-02-25. The shares were previously bought for an average price of . The CVS Health Corp shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold CVS share for is so the ETF has sold 301 shares on 2025-02-25 at a higher price than the previous selling average. |
| CSL.AX - | SELL | -117 @ 166.235 | -19,449 | The ETF sold 117 shares of CSL.AX on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold CSL.AX share for is so the ETF has sold 117 shares on 2025-02-25 at a higher price than the previous selling average. |
| EL.PA - EssilorLuxottica SA | SELL | -71 @ 293.314 | -20,825 | The ETF sold 71 shares of EL.PA on 2025-02-25. The shares were previously bought for an average price of . The EssilorLuxottica SA shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold EL.PA share for is so the ETF has sold 71 shares on 2025-02-25 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -723 @ 33.28 | -24,061 | The ETF sold 723 shares of MRNA on 2025-02-25. The shares were previously bought for an average price of 43.66. The Moderna Inc shares were sold for -23.8% lower than average price of previous purchases. This resulted in an overall loss of 7,505 The average price that the ETF previously sold MRNA share for is so the ETF has sold 723 shares on 2025-02-25 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -310 @ 90.48 | -28,049 | The ETF sold 310 shares of MDT on 2025-02-25. The shares were previously bought for an average price of . The Medtronic PLC shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold MDT share for is so the ETF has sold 310 shares on 2025-02-25 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -488 @ 58.21 | -28,406 | The ETF sold 488 shares of BMY on 2025-02-25. The shares were previously bought for an average price of . The Bloomsbury Publishing Plc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BMY share for is so the ETF has sold 488 shares on 2025-02-25 at a higher price than the previous selling average. |
| SAN.PA - Sanofi SA | SELL | -275 @ 109.284 | -30,053 | The ETF sold 275 shares of SAN.PA on 2025-02-25. The shares were previously bought for an average price of . The Sanofi SA shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold SAN.PA share for is so the ETF has sold 275 shares on 2025-02-25 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -126 @ 249.223 | -31,402 | The ETF sold 126 shares of SRT3.DE on 2025-02-25. The shares were previously bought for an average price of . The Sartorius AG shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold SRT3.DE share for is so the ETF has sold 126 shares on 2025-02-25 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -82 @ 390.3 | -32,005 | The ETF sold 82 shares of SYK on 2025-02-25. The shares were previously bought for an average price of . The Stryker Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold SYK share for is so the ETF has sold 82 shares on 2025-02-25 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -156 @ 210.41 | -32,824 | The ETF sold 156 shares of DHR on 2025-02-25. The shares were previously bought for an average price of . The Danaher Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold DHR share for is so the ETF has sold 156 shares on 2025-02-25 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -156 @ 210.41 | -32,824 | The ETF sold 156 shares of DHR on 2025-02-25. The shares were previously bought for an average price of . The Danaher Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold DHR share for is so the ETF has sold 156 shares on 2025-02-25 at a higher price than the previous selling average. |
| 4523.T - Eisai Co., Ltd. | SELL | -1,200 @ JPY 29.3256 | JPY -35,191 | The ETF sold 1200 shares of 4523.T on 2025-02-25. The shares were previously bought for an average price of JPY 28.8144. The Eisai Co., Ltd. shares were sold for 1.8% higher than average price of previous purchases. This sale made a profit of JPY 613 (USD $4) The average price that the ETF previously sold 4523.T share for is JPY so the ETF has sold 1200 shares on 2025-02-25 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -354 @ 100.72 | -35,655 | The ETF sold 354 shares of BSX on 2025-02-25. The shares were previously bought for an average price of . The Boston Scientific Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BSX share for is so the ETF has sold 354 shares on 2025-02-25 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -354 @ 100.72 | -35,655 | The ETF sold 354 shares of BSX on 2025-02-25. The shares were previously bought for an average price of . The MULSTRXSSXIMETFP shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold BSX share for is so the ETF has sold 354 shares on 2025-02-25 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -1,357 @ 26.74 | -36,286 | The ETF sold 1357 shares of PFE on 2025-02-25. The shares were previously bought for an average price of . The Pfizer Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold PFE share for is so the ETF has sold 1357 shares on 2025-02-25 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -129 @ 315.63 | -40,716 | The ETF sold 129 shares of AMGN on 2025-02-25. The shares were previously bought for an average price of . The Amgen Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold AMGN share for is so the ETF has sold 129 shares on 2025-02-25 at a higher price than the previous selling average. |
| QIA.DE - QIAGEN NV | SELL | -1,040 @ 39.5512 | -41,133 | The ETF sold 1040 shares of QIA.DE on 2025-02-25. The shares were previously bought for an average price of . The QIAGEN NV shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold QIA.DE share for is so the ETF has sold 1040 shares on 2025-02-25 at a higher price than the previous selling average. |
| 6869.T - Sysmex Corporation | SELL | -2,400 @ JPY 18.2513 | JPY -43,803 | The ETF sold 2400 shares of 6869.T on 2025-02-25. The shares were previously bought for an average price of JPY . The Sysmex Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold 6869.T share for is JPY so the ETF has sold 2400 shares on 2025-02-25 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -85 @ 573.74 | -48,768 | The ETF sold 85 shares of ISRG on 2025-02-25. The shares were previously bought for an average price of . The Intuitive Surgical Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold ISRG share for is so the ETF has sold 85 shares on 2025-02-25 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -91 @ 539.55 | -49,099 | The ETF sold 91 shares of TMO on 2025-02-25. The shares were previously bought for an average price of 580.57. The Time Out Group plc shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of 3,733 The average price that the ETF previously sold TMO share for is so the ETF has sold 91 shares on 2025-02-25 at a higher price than the previous selling average. |
| COH.AX - | SELL | -312 @ 169.104 | -52,760 | The ETF sold 312 shares of COH.AX on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold COH.AX share for is so the ETF has sold 312 shares on 2025-02-25 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -609 @ 91.43 | -55,681 | The ETF sold 609 shares of MRK on 2025-02-25. The shares were previously bought for an average price of 100.05. The Marks Electrical Group PLC shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of 5,250 The average price that the ETF previously sold MRK share for is so the ETF has sold 609 shares on 2025-02-25 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -609 @ 91.43 | -55,681 | The ETF sold 609 shares of MRK on 2025-02-25. The shares were previously bought for an average price of 100.05. The Merck & Company Inc shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of 5,250 The average price that the ETF previously sold MRK share for is so the ETF has sold 609 shares on 2025-02-25 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -290 @ 194.318 | -56,352 | The ETF sold 290 shares of UCB.BR on 2025-02-25. The shares were previously bought for an average price of 193.198. The UCB SA shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of 325 The average price that the ETF previously sold UCB.BR share for is so the ETF has sold 290 shares on 2025-02-25 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -169 @ 334.956 | -56,608 | The ETF sold 169 shares of ROG.SW on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold ROG.SW share for is so the ETF has sold 169 shares on 2025-02-25 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -418 @ 135.82 | -56,773 | The ETF sold 418 shares of ABT on 2025-02-25. The shares were previously bought for an average price of . The Abbott Laboratories shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold ABT share for is so the ETF has sold 418 shares on 2025-02-25 at a higher price than the previous selling average. |
| AVTR - Avantor Inc | SELL | -3,263 @ 17.56 | -57,298 | The ETF sold 3263 shares of AVTR on 2025-02-25. The shares were previously bought for an average price of 21.1619. The Avantor Inc shares were sold for -17.0% lower than average price of previous purchases. This resulted in an overall loss of 11,753 The average price that the ETF previously sold AVTR share for is so the ETF has sold 3263 shares on 2025-02-25 at a higher price than the previous selling average. |
| 4519.T - Chugai Pharmaceutical Co., Ltd. | SELL | -1,200 @ JPY 52.7618 | JPY -63,314 | The ETF sold 1200 shares of 4519.T on 2025-02-25. The shares were previously bought for an average price of JPY . The Chugai Pharmaceutical Co., Ltd. shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold 4519.T share for is JPY so the ETF has sold 1200 shares on 2025-02-25 at a higher price than the previous selling average. |
| COLO-B.CO - | SELL | -601 @ 113.207 | -68,037 | The ETF sold 601 shares of COLO-B.CO on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold COLO-B.CO share for is so the ETF has sold 601 shares on 2025-02-25 at a higher price than the previous selling average. |
| GMAB.CO - | SELL | -302 @ 230.383 | -69,576 | The ETF sold 302 shares of GMAB.CO on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold GMAB.CO share for is so the ETF has sold 302 shares on 2025-02-25 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -1,114 @ 65.23 | -72,666 | The ETF sold 1114 shares of HOLX on 2025-02-25. The shares were previously bought for an average price of 71.58. The Hologic Inc shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of 7,074 The average price that the ETF previously sold HOLX share for is so the ETF has sold 1114 shares on 2025-02-25 at a higher price than the previous selling average. |
| SOON.SW - | SELL | -242 @ 326.898 | -79,109 | The ETF sold 242 shares of SOON.SW on 2025-02-25. The shares were previously bought for an average price of . The shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold SOON.SW share for is so the ETF has sold 242 shares on 2025-02-25 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -270 @ 305.97 | -82,612 | The ETF sold 270 shares of MOH on 2025-02-25. The shares were previously bought for an average price of . The MOH shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold MOH share for is so the ETF has sold 270 shares on 2025-02-25 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -270 @ 305.97 | -82,612 | The ETF sold 270 shares of MOH on 2025-02-25. The shares were previously bought for an average price of . The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold MOH share for is so the ETF has sold 270 shares on 2025-02-25 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -420 @ 204.14 | -85,739 | The ETF sold 420 shares of ABBV on 2025-02-25. The shares were previously bought for an average price of . The AbbVie Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold ABBV share for is so the ETF has sold 420 shares on 2025-02-25 at a higher price than the previous selling average. |
| 4503.T - Astellas Pharma Inc. | SELL | -8,600 @ JPY 10.0245 | JPY -86,211 | The ETF sold 8600 shares of 4503.T on 2025-02-25. The shares were previously bought for an average price of JPY . The Astellas Pharma Inc. shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold 4503.T share for is JPY so the ETF has sold 8600 shares on 2025-02-25 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -574 @ 166.09 | -95,336 | The ETF sold 574 shares of JNJ on 2025-02-25. The shares were previously bought for an average price of . The Johnson & Johnson shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold JNJ share for is so the ETF has sold 574 shares on 2025-02-25 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -472 @ 223.79 | -105,629 | The ETF sold 472 shares of STE on 2025-02-25. The shares were previously bought for an average price of 216.197. The STERIS plc shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of 3,584 The average price that the ETF previously sold STE share for is so the ETF has sold 472 shares on 2025-02-25 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -283 @ 380.83 | -107,775 | The ETF sold 283 shares of WAT on 2025-02-25. The shares were previously bought for an average price of . The Waters Corporation shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold WAT share for is so the ETF has sold 283 shares on 2025-02-25 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -283 @ 380.83 | -107,775 | The ETF sold 283 shares of WAT on 2025-02-25. The shares were previously bought for an average price of . The MULETFWATIMETFP shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold WAT share for is so the ETF has sold 283 shares on 2025-02-25 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -308 @ 470.38 | -144,877 | The ETF sold 308 shares of UNH on 2025-02-25. The shares were previously bought for an average price of 605.439. The UnitedHealth Group Incorporated shares were sold for -22.3% lower than average price of previous purchases. This resulted in an overall loss of 41,598 The average price that the ETF previously sold UNH share for is so the ETF has sold 308 shares on 2025-02-25 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -560 @ 259.27 | -145,191 | The ETF sold 560 shares of HUM on 2025-02-25. The shares were previously bought for an average price of 304.147. The Hummingbird Resources PLC shares were sold for -14.8% lower than average price of previous purchases. This resulted in an overall loss of 25,131 The average price that the ETF previously sold HUM share for is so the ETF has sold 560 shares on 2025-02-25 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -560 @ 259.27 | -145,191 | The ETF sold 560 shares of HUM on 2025-02-25. The shares were previously bought for an average price of 304.147. The Humana Inc shares were sold for -14.8% lower than average price of previous purchases. This resulted in an overall loss of 25,131 The average price that the ETF previously sold HUM share for is so the ETF has sold 560 shares on 2025-02-25 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -1,153 @ 127.81 | -147,365 | The ETF sold 1153 shares of CAH on 2025-02-25. The shares were previously bought for an average price of . The Cardinal Health Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold CAH share for is so the ETF has sold 1153 shares on 2025-02-25 at a higher price than the previous selling average. |
| 4568.T - Daiichi Sankyo Company, Limited | SELL | -6,600 @ JPY 23.1479 | JPY -152,776 | The ETF sold 6600 shares of 4568.T on 2025-02-25. The shares were previously bought for an average price of JPY 29.7492. The Daiichi Sankyo Company, Limited shares were sold for -22.2% lower than average price of previous purchases. This resulted in an overall loss of JPY 43,569 (USD $291) The average price that the ETF previously sold 4568.T share for is JPY so the ETF has sold 6600 shares on 2025-02-25 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -2,508 @ 61.33 | -153,816 | The ETF sold 2508 shares of CNC on 2025-02-25. The shares were previously bought for an average price of . The Concurrent Technologies Plc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold CNC share for is so the ETF has sold 2508 shares on 2025-02-25 at a higher price than the previous selling average. |
| VEEV - Veeva Systems Inc Class A | SELL | -733 @ 221.36 | -162,257 | The ETF sold 733 shares of VEEV on 2025-02-25. The shares were previously bought for an average price of . The Veeva Systems Inc Class A shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold VEEV share for is so the ETF has sold 733 shares on 2025-02-25 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -866 @ 190.97 | -165,380 | The ETF sold 866 shares of IQV on 2025-02-25. The shares were previously bought for an average price of 204.02. The IQVIA Holdings Inc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of 11,301 The average price that the ETF previously sold IQV share for is so the ETF has sold 866 shares on 2025-02-25 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -393 @ 459.86 | -180,725 | The ETF sold 393 shares of IDXX on 2025-02-25. The shares were previously bought for an average price of 465.03. The IDEXX Laboratories Inc shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of 2,032 The average price that the ETF previously sold IDXX share for is so the ETF has sold 393 shares on 2025-02-25 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -1,365 @ 134.18 | -183,156 | The ETF sold 1365 shares of A on 2025-02-25. The shares were previously bought for an average price of . The Agilent Technologies Inc shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold A share for is so the ETF has sold 1365 shares on 2025-02-25 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -757 @ 250.53 | -189,651 | The ETF sold 757 shares of COR on 2025-02-25. The shares were previously bought for an average price of 251.57. The Cencora Inc. shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of 787 The average price that the ETF previously sold COR share for is so the ETF has sold 757 shares on 2025-02-25 at a higher price than the previous selling average. |
| ALC.SW - | SELL | -2,152 @ 89.7096 | -193,055 | The ETF sold 2152 shares of ALC.SW on 2025-02-25. The shares were previously bought for an average price of 85.8897. The shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of 8,220 The average price that the ETF previously sold ALC.SW share for is so the ETF has sold 2152 shares on 2025-02-25 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -2,784 @ 71.45 | -198,917 | The ETF sold 2784 shares of EW on 2025-02-25. The shares were previously bought for an average price of 71.33. The Edwards Lifesciences Corp shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of 334 The average price that the ETF previously sold EW share for is so the ETF has sold 2784 shares on 2025-02-25 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -1,225 @ 168.53 | -206,449 | The ETF sold 1225 shares of ZTS on 2025-02-25. The shares were previously bought for an average price of 172.24. The Zoetis Inc shares were sold for -2.2% lower than average price of previous purchases. This resulted in an overall loss of 4,545 The average price that the ETF previously sold ZTS share for is so the ETF has sold 1225 shares on 2025-02-25 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -707 @ 313.9 | -221,927 | The ETF sold 707 shares of CI on 2025-02-25. The shares were previously bought for an average price of . The Cigna Corp shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold CI share for is so the ETF has sold 707 shares on 2025-02-25 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -359 @ 627.08 | -225,122 | The ETF sold 359 shares of MCK on 2025-02-25. The shares were previously bought for an average price of 603.32. The McKesson Corporation shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of 8,530 The average price that the ETF previously sold MCK share for is so the ETF has sold 359 shares on 2025-02-25 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -578 @ 401.93 | -232,316 | The ETF sold 578 shares of ELV on 2025-02-25. The shares were previously bought for an average price of 407.538. The Elevance Health Inc shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of 3,241 The average price that the ETF previously sold ELV share for is so the ETF has sold 578 shares on 2025-02-25 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -578 @ 401.93 | -232,316 | The ETF sold 578 shares of ELV on 2025-02-25. The shares were previously bought for an average price of 407.538. The Elevance Health Inc shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of 3,241 The average price that the ETF previously sold ELV share for is so the ETF has sold 578 shares on 2025-02-25 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -543 @ 480.35 | -260,830 | The ETF sold 543 shares of VRTX on 2025-02-25. The shares were previously bought for an average price of 482.28. The Vertex Pharmaceuticals Inc shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of 1,048 The average price that the ETF previously sold VRTX share for is so the ETF has sold 543 shares on 2025-02-25 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -2,772 @ 111.53 | -309,161 | The ETF sold 2772 shares of GILD on 2025-02-25. The shares were previously bought for an average price of 97.99. The Guild Esports Plc shares were sold for 13.8% higher than average price of previous purchases. This sale made a profit of 37,533 The average price that the ETF previously sold GILD share for is so the ETF has sold 2772 shares on 2025-02-25 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -2,183 @ 150.982 | -329,594 | The ETF sold 2183 shares of AZN.L on 2025-02-25. The shares were previously bought for an average price of 131.467. The AstraZeneca PLC shares were sold for 14.8% higher than average price of previous purchases. This sale made a profit of 42,601 The average price that the ETF previously sold AZN.L share for is so the ETF has sold 2183 shares on 2025-02-25 at a higher price than the previous selling average. |
| NOVN.SW - | SELL | -3,290 @ 112.719 | -370,846 | The ETF sold 3290 shares of NOVN.SW on 2025-02-25. The shares were previously bought for an average price of 103.821. The shares were sold for 8.6% higher than average price of previous purchases. This sale made a profit of 29,274 The average price that the ETF previously sold NOVN.SW share for is so the ETF has sold 3290 shares on 2025-02-25 at a higher price than the previous selling average. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -4,439 @ 92.4629 | -410,443 | The ETF sold 4439 shares of NOVO-B.CO on 2025-02-25. The shares were previously bought for an average price of 82.4671. The Novo Nordisk A/S shares were sold for 12.1% higher than average price of previous purchases. This sale made a profit of 44,371 The average price that the ETF previously sold NOVO-B.CO share for is so the ETF has sold 4439 shares on 2025-02-25 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -531 @ 901.8 | -478,856 | The ETF sold 531 shares of LLY on 2025-02-25. The shares were previously bought for an average price of 756.141. The Eli Lilly and Company shares were sold for 19.3% higher than average price of previous purchases. This sale made a profit of 77,345 The average price that the ETF previously sold LLY share for is so the ETF has sold 531 shares on 2025-02-25 at a higher price than the previous selling average. |